Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05793151 · ClinicalTrials.gov registry record · NA

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

A NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
532
Enrollment target
4
Study locations

NCT05793151 is a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 532 participants, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (105% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05793151, a NA study of Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
532 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to compare the effectiveness of a navigation-based multilevel intervention (ENDURE) with treatment as usual (TAU) to improve the initiation of guideline-adherent postoperative radiation therapy among patients with head and neck cancer. The main questions the trial aims to answer are: 1. Does ENDURE improve initiation of timely PORT relative to treatment as usual? 2. What are the mechanisms through which ENDURE improves timeliness to treatment? 3. What are the barriers and facilitators to the implementation of ENDURE into routine clinical care?

Conditions Studied

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Oropharynx Cancer Oral Cavity Cancer Larynx Cancer

Interventions

  • BEHAVIORAL ENDURE

Study Locations (4)

Missouri

  • Washington University in St. Louis - St Louis

North Carolina

  • Duke University Medical Center - Durham

South Carolina

  • Medical University of South Carolina - Charleston

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 532 participants
Start Date 2023-10-30
Est. Completion 2028-03-30
Phase NA

Sponsor

Medical University of South Carolina

755 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05793151

The ClinicalTrials.gov registry entry for NCT05793151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (105% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which ENDURE is the first listed.

NCT05793151 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Missouri, North Carolina, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05793151 about?

NCT05793151 is a clinical study titled "Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy". The goal of this clinical trial is to compare the effectiveness of a navigation-based multilevel intervention (ENDURE) with treatment as usual (TAU) to improve the initiation of guideline-adherent postoperative radiation therapy among patients with head and neck cancer. The main questions the trial ...

What is the current status of trial NCT05793151?

This trial is currently recruiting. It is a NA study. The enrollment target is 532 participants. The study started on 2023-10-30. Estimated completion is 2028-03-30.

What conditions does trial NCT05793151 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer, Oral Cavity Cancer, Larynx Cancer.

What interventions are being tested in trial NCT05793151?

The interventions under investigation include: ENDURE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05793151?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05793151 being conducted?

This trial has 4 study locations across Missouri, North Carolina, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Head and Neck Squamous Cell Carcinoma

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.